Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ABL1 | P00519 | 2/20 | 0.64 |
| ▸ | BCR | P11274 | 2/20 | 0.64 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.47 |
| ▸ | AURKA | O14965 | 1/20 | 0.45 |
| ▸ | MCHR1 | Q99705 | 6/20 | 0.43 |
| ▸ | HTR2C | P28335 | 4/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | NPC1 | O15118 | 1/20 | 0.40 |
| ▸ | RAB9A | P51151 | 1/20 | 0.40 |
| ▸ | ACKR3 | P25106 | 3/20 | 0.40 |
| ▸ | KDR | P35968 | 1/20 | 0.40 |
| ▸ | ENPP2 | Q13822 | 1/20 | 0.40 |
| ▸ | NTRK1 | P04629 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL742456 | 0.99 | ABL1 (0.65) | ABL1BCRCYP2C9AURKAMCHR1 | |
| SCHEMBL742951 | 0.98 | ABL1 (0.62) | ABL1BCRCYP2C9AURKAMCHR1 | |
| SCHEMBL739685 | 0.93 | ABL1 (0.56) | ABL1BCRCYP2C9AURKASMN1; SMN2 | |
| SCHEMBL742638 | 0.93 | ABL1 (0.74) | ABL1BCRCYP2C9AURKAMCHR1 | |
| SCHEMBL740581 | 0.92 | ABL1 (0.63) | ABL1BCRCYP2C9AURKASMN1; SMN2 | |
| SCHEMBL741183 | 0.92 | ABL1 (0.76) | ABL1BCRCYP2C9AURKAKDM4E | |
| SCHEMBL740752 | 0.92 | ABL1 (0.76) | ABL1BCRCYP2C9AURKAKDM4E | |
| SCHEMBL742939 | 0.92 | ABL1 (0.64) | ABL1BCRCYP2C9AURKASMN1; SMN2 | |
| SCHEMBL740623 | 0.91 | ABL1 (0.72) | ABL1BCRCYP2C9AURKAKDM4E | |
| SCHEMBL741731 | 0.91 | ABL1 (0.61) | ABL1BCRCYP2C9AURKASMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8138217-B2 | Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2012-03-20 | — | — | US | claimed |
| US-8138217-B2 | Aurora kinase inhibitors; proliferative disorders; anticancer agents; antitumor agents; N-(1-methyl-1-phenylethyl)-3-((4-morpholin-4-ylbenzoyl)amino)-1H-thieno(2,3-c)pyrazole-5-carboxamide | NERVIANO MEDICAL SCIENCES S.R.L. (IT) | 2012-03-20 | — | — | US | disclosed |